The prognostic value of perioperative, pre‐systemic therapy CA125 levels in patients with high‐grade serous ovarian cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1879-3479|140|2|247-252

ISSN： 0020-7292

Source： International Federation of Gynecology and Obstetrics, Vol.140, Iss.2, 2018-02, pp. : 247-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficient molecular subtype classification of high‐grade serous ovarian cancer

By  

THE JOURNAL OF PATHOLOGY, Vol. 236, Iss. 3, 2015-07 ,pp. : 272-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer

By  

Case Reports in Oncology, Vol. 8, Iss. 2, 2015-07 ,pp. : 290-294

Karger

Access to resources Recommend Favorite

Comprehensive mutation profiling by next‐generation sequencing of effusion fluids from patients with high‐grade serous ovarian carcinoma

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 5, 2015-05 ,pp. : 289-297

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lipocalin‐2 and matrix metalloproteinase‐9 expression in high‐grade endometrial cancer and their prognostic value

By  

HISTOPATHOLOGY, Vol. 67, Iss. 2, 2015-08 ,pp. : 206-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Value of Pre- and Postoperative Anti-p53 Antibody Levels in Colorectal Cancer Patients: A Retrospective Study

By  

Oncology, Vol. 92, Iss. 1, 2016-10 ,pp. : 31-38

Karger

Access to resources Recommend Favorite